Tower Research Capital (TRC)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191K | Buy |
|
|||||
|
2025
Q1 | $43.7K | Sell |
|
|||||
|
2024
Q4 | $230K | Buy |
|
|||||
|
2024
Q3 | $12.6K | Sell |
|
|||||
|
2024
Q2 | $484K | Buy |
|
|||||
|
2024
Q1 | $29.2K | Sell |
|
|||||
|
2023
Q4 | $123K | Buy |
|
|||||
|
2023
Q3 | $35.2K | Sell |
|
|||||
|
2023
Q2 | $177K | Buy |
|
|||||
|
2023
Q1 | $92K | Buy |
|
|||||
|
2022
Q4 | $44K | Sell |
|
|||||
|
2022
Q3 | $437K | Buy |
|
|||||
|
2022
Q2 | $309K | Buy |
|
|||||
|
2022
Q1 | $68K | Sell |
|
|||||
|
2021
Q4 | $328K | Buy |
|
|||||
|
2021
Q3 | $273K | Buy |
|
|||||
|
2021
Q2 | $355K | Sell |
|
|||||
|
2021
Q1 | $437K | Buy |
|
|||||
|
2020
Q4 | $338K | Buy |
|
|||||
|
2020
Q3 | $83K | Sell |
|
|||||
|
2020
Q2 | $232K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $32K | Buy |
|
|||||
|
2019
Q2 | $2K | Sell |
|
|||||
|
2019
Q1 | $19K | Buy |
|
|||||
|
2018
Q4 | $2K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $56K | Buy |
|